A pharma giant is moving past one patent cliff — but another is already looming
Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.
बातमीचा सारांश
Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.
विश्वसनीय प्रकाशकांच्या ताज्या बातम्या संक्षिप्त सारांशासह वाचा. तपशीलांसाठी मूळ स्रोताची लिंक उघडा.